Trials / Active Not Recruiting
Active Not RecruitingNCT04493749
Clinical Performance of Withings Move ECG Software for Atrial Fibrillation Detection
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 234 (estimated)
- Sponsor
- Withings · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Withings Move ECG watch is designed to record ECG and detect automatically atrial fibrillation. The aim of this study is to validate the performance of Move ECG watch to detect atrial fibrillation compared to a reference 12-lead ECG.
Detailed description
Patients with atrial fibrillation are included in hospitals. On each patient, ECG with Move ECG and the reference 12-lead ECG are recorded simultaneously. Both records are then reviewed by independent cardiologists to assess 1. The presence or absence of atrial fibrillation 2. if waveforms of ECG recorded with Move ECG compared with the reference.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | ECG measurement | Simultaneous recording of a single-lead ECG signal with the Withings Move ECG and ECG signal for the reference 12-lead ECG |
Timeline
- Start date
- 2019-12-20
- Primary completion
- 2021-03-15
- Completion
- 2026-10-15
- First posted
- 2020-07-30
- Last updated
- 2026-02-18
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04493749. Inclusion in this directory is not an endorsement.